Table 1.
Summary of the main characteristics and outcomes of the included studies
| Author | Year | Type of study | Nº of patients | Nº of implants | Type of mesh | Bone Graft | Bone gain Vertical (mm) | Bone gain horizontal (mm) | Membrane exposure (%) | Other complications (%) | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiapasco et al. [17] | 2021 | RS | 41 | 106 | CAD/CAM | MIX: Auto + DBBM | 4.78 ± 1.88 | 6.35 ± 2.10 | 20.7 | 2.5 | 10.6 ± 6.5 |
| Corinadelsi et al. [19] | 2009 | RS | 24 | 56 | Conventional | Auto | 5.45 ± 1.16 | NA | 14. 8 | NA | 39–96 |
| Cucchi et al. [28] | 2017 | RCT | 20 | 108 | Conventional | MIX: Auto + ALO | 4.1 ± 1.0 | NA | 21.1 | 15.8 | 6–9 |
| Dellavia et al. [26] | 2021 | CS | 20 | 48 | CAD/CAM | MIX: Auto + DBBM | 5.20 ± 1.76 | 6.8 ± 2.51 | 15 | NA | 9 |
| El Chaar et al. [20] | 2019 | RS | 39 | 63 | Conventional | Allograft | 6.37 | 6.42 | 46.15 | 10.25 | 18–48 |
| Gomes et al. [31] | 2016 | RS | 25 | 40 | Conventional | DBBM | NA | 3.67 ± 0.89 | 24 | 48 | 12 |
| Hartmann et al. [33] | 2020 | RS | 55 | 98 | CAD/CAM | MIX: Auto + DBBM | NA | NA | 25 | NA | 6.53 ± 2.7 |
| Her et al. [10] | 2012 | RS | 26 | 69 | Conventional | DBBM | NA | NA | 26 | NA | 6–24 |
| Jung et al. [34] | 2014 | PS | 10 | 12 | CAD/CAM | MIX: Auto + ALO | NA | NA | 3 | NA | 12 |
| Lizio et al. [13] | 2016 | PS | 24 | 88 | Conventional | MIX: Auto + DBBM | NA | NA | 58.82 | 11.76 | 6–12 |
| Louis et al. [21] | 2008 | RS | 44 | 174 | Conventional | MIX: Auto + DBBM | 13.5 ± 1.7 | NA | 52.3 | NA | 3-6-9 |
| Miyamoto et al. [22] | 2012 | RS | 27 | 87 | Conventional | Auto | 5.4 ± 3.4 | 3.7 ± 2.0 | 40.7 | 66.66 | 47.5 |
| Poli et al. [32] | 2014 | RS | 13 | 20 | Conventional | MIX: Auto + DBBM | NA | NA | 7.69 | NA | 88 |
| Rocuzzo et al. [24] | 2007 | PS | 12 | NA | Conventional | Autogenous Block | 5.7 ± 1.5 | 3.4 | 33.3 | NA | 4–6 |
| Sagheb et al. [18] | 2017 | PS | 17 | 44 | CAD/CAM | MIX: Auto + DBBM | 6.5 ± 1.7 | 5.5 ± 1.9 | 33 | NA | 6–12 |
| Torres et al. [25] | 2010 | RCT | 30 | 97 | Conventional | Anorganic bovine Bone (ABB) | 3.3 ± 0.2 | 3.9 ± 0.2 | 20 | NA | 24 |
| Nan et al. [27] | 2023 | RS | 59 | 80 | CAD/CAM | MIX: Auto + DBBM | 5.01 ± 2.83 | 5.22 ± 3.19 | 32.8 | NA | 12 |
| Li et al. [30] | 2023 | RS | 36 | 57 | CAD/CAM | MIX: Auto + DBBM | 2.38 ± 2.69 | 5.37 ± 2.01 | 16.67 | NA | 6–8 |
| Cucchi et al. [12] | 2021 | RCT | 30 | 71 | CAD/CAM | MIX: Auto + DBBM | 5.55 ± 2.38 | NA | 23.3 | 6.6 | 6 |
| Pellegrino et al. [28] | 2024 | PS | 16 | NA | CAD/CAM | MIX: Auto + DBBM | 5,89 ± 0.45 | 9.52 ± 0.65 | 12.5 | NA | 8 |
| Chen et al. [16] | 2023 | RS | 30 | NA | CAD/CAM | MIX: Auto + DBBM | 5.02 ± 1.42 | NA | 30 | 0 | 6 |
| Hernández-Alfaro et al. [29] | 2024 | PS | 10 | NA | CAD/CAM | MIX: Auto + DBBM | 5.87 ± 1.6 | 5.64 ± 2.1 | 20 | 0 | 6 |
Abbreviations: RCT, randomized controlled trial; RS, retrospective study; PS, prospective study; CS, case series; Auto, autologous bone; DBBM, deproteinized bovine bone mineral; ALO, allograft; ABB, anorganic bovine bone; CAD/CAM, computer-aided design/computer-aided manufacturing; NA, not available